Junying Xu

发表

The Importance of a Conjoint Analysis of Tumor-Associated Macrophages and Immune Checkpoints in Pancreatic Cancer.

Junying Xu, Wang-Sheng Wang, Jing Zhou, 2019, Pancreas.

HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC

Jie Mei, W. Mao, Junying Xu, 2022, BMC cancer.

NY-ESO-1 expression in solid tumors predicts prognosis

Huiyu Wang, Jie Mei, Chaoying Liu, 2019, Medicine.

Functional, UV-curable coating for the capture of circulating tumor cells.

Huiyu Wang, Chaoying Liu, Junying Xu, 2019, Biomaterials science.

Case Report: Successful Immunotherapy Improved the Prognosis of the Unfavorable Subset of Cancer of Unknown Primary

Jie Mei, Hong-hong Fan, Junying Xu, 2022, Frontiers in Immunology.

High-dose fulvestrant as third-line endocrine therapy for breast cancer metastasis to the left kidney

Huiyu Wang, Chaoying Liu, Junying Xu, 2018, Medicine.

NEUROD1 predicts better prognosis in pancreatic cancer revealed by a TILs-based prognostic signature

Huiyu Wang, Jie Mei, Rui Xu, 2022, Frontiers in Pharmacology.

Microfluidic devices: The application in TME modeling and the potential in immunotherapy optimization

Yuting Li, Huiyu Wang, Hong-hong Fan, 2022, Frontiers in Genetics.

The Clinical Significance of Deglycosylated PD-L1 Level Detection Using 28-8 Monoclonal Antibody in Lung Adenocarcinoma

Huiyu Wang, D. Hua, Jie Mei, 2022, International journal of general medicine.

ZEB1: Catalyst of immune escape during tumor metastasis.

Peihua Lu, Jie Mei, Junying Xu, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

KU-0060648 inhibits hepatocellular carcinoma cells through DNA-PKcs-dependent and DNA-PKcs-independent mechanisms

Gang Chen, Junying Xu, Pei-hua Lu, 2016, Oncotarget.

High expression COL10A1 promotes breast cancer progression and predicts poor prognosis

Huiyu Wang, Chaoying Liu, Junying Xu, 2022, Heliyon.

lncRNA LINC00460 Functions as a Competing Endogenous RNA and Regulates Expression of BGN by Sponging miR-149-5p in Colorectal Cancer

Junying Xu, Juying Zhou, Shourong Lu, 2021, Technology in cancer research & treatment.

The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy

Y. Chu, Ronghua Liu, Junying Xu, 2018, Journal of Neuroinflammation.

A comparability study of natural and deglycosylated PD-L1 levels in lung cancer: evidence from immunohistochemical analysis

Huiyu Wang, Jie Mei, Chaoying Liu, 2021, Molecular cancer.

Wnt5a: A promising therapeutic target in ovarian cancer.

Huiyu Wang, Jie Mei, Chaoying Liu, 2021, Pathology, research and practice.

SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers

Yongmei Yin, Z. Fu, Yichao Zhu, 2023, iScience.

Pan‐cancer analysis revealing DAAM1 as a novel predictive biomarker for PD‐1/PD‐L1 blockade in clear cell renal cell carcinoma

Yichao Zhu, Jie Mei, Hong-hong Fan, 2022, MedComm.

Clinical implication of TMPRSS4 expression in human gallbladder cancer

Junying Xu, Chao-ying Liu, Ming Zhang, 2014, Tumor Biology.

The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy

Y. Chu, Ronghua Liu, Junying Xu, 2018, Journal of Neuroinflammation.

Formin protein DIAPH1 positively regulates PD-L1 expression and predicts the therapeutic response to anti-PD-1/PD-L1 immunotherapy.

Yun Cai, Yichao Zhu, Huiyu Wang, 2022, Clinical immunology.

Biochanin A Suppresses Tumor Progression and PD-L1 Expression via Inhibiting ZEB1 Expression in Colorectal Cancer

D. Hua, Jie Mei, Hong-hong Fan, 2022, Journal of oncology.

A comprehensive pan-cancer analysis of CD274 gene amplification, tumor mutation burden, microsatellite instability, and PD-L1 expression in Chinese cancer patients

G. Gao, Kai Chen, Junying Xu, 2021, Annals of translational medicine.

Removal of N-Linked Glycosylation Enhances PD-L1 Detection in Colon Cancer: Validation Research Based on Immunohistochemistry Analysis

Huiyu Wang, D. Hua, Y. Mao, 2021, Technology in cancer research & treatment.

GBP5 Identifies Immuno-Hot Tumors and Predicts the Therapeutic Response to Immunotherapy in NSCLC

Huiyu Wang, Jie Mei, Yuting Li, 2023, International journal of general medicine.

Abiraterone suppresses irradiated lung cancer cells-induced angiogenic capacities of endothelial cells

Liping Jiang, Junying Xu, Juying Zhou, 2021, Journal of Bioenergetics and Biomembranes.

Total T Cell Density and Expression of T Memory Stem Cell Markers are Associated with Better Prognosis in Colon Cancer

Jie Mei, Hong-hong Fan, Junying Xu, 2023, International journal of general medicine.

Physical exercise reverses immuno-cold tumor microenvironment via inhibiting SQLE in non-small cell lung cancer

H. Chen, Jie Mei, W. Mao, 2023, Military Medical Research.

Protocol to identify novel immunotherapy biomarkers based on transcriptomic data in human cancers

Yongmei Yin, Yichao Zhu, Jie Mei, 2023, STAR protocols.

A systematic review and meta-analysis

Huiyu Wang, Junying Xu, Datian Chen, 2019 .

Conserved immuno‐collagenic subtypes predict response to immune checkpoint blockade

Jiahui Chu, Junying Xu, Zhiwen Luo, 2024, Cancer communications.

Voluntary exercise sensitizes cancer immunotherapy via the collagen inhibition-orchestrated inflammatory tumor immune microenvironment.

Junying Xu, Zhiwen Luo, Shiyi Chen, 2024, Cell reports.

HOXC10 promotes esophageal squamous cell carcinoma progression by targeting FOXA3 and indicates poor survival outcome

Huiyu Wang, Junying Xu, Xiaoting He, 2023, Heliyon.